UTHR
NASDAQ · Biotechnology
United Therapeutics Corp
$538.84
+5.90 (+1.11%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
+13.87%
1Y
+79.36%
YTD
+8.48%
Open$534.84
Previous Close$532.94
Day High$541.03
Day Low$524.58
52W High$609.35
52W Low$292.34
Volume—
Avg Volume553.2K
Market Cap22.77B
P/E Ratio17.69
EPS$27.09
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$485.49
Above
SMA 200
$394.55
Above
RSI (14)
60.3
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
22 analysts
Price Target
-83.6% upside
Current
$538.84
$538.84
Target
$88.53
$88.53
$65.70
$88.53 avg
$121.74
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 2.81B | 2.38B | 2.73B |
| Net Income | 1.18B | 898.10M | 406.29M |
| Profit Margin | 41.9% | 39.8% | 14.9% |
| EBITDA | 1.39B | 1.12B | 733.08M |
| Free Cash Flow | — | — | 513.48M |
| Rev Growth | +18.0% | +18.0% | +4.0% |
| Debt/Equity | — | — | 0.52 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $246.04 | +0.89% | 118.6 | 430.95B |
| AMGN | Amgen Inc | $410.95 | +1.51% | 25.1 | 219.39B |
| GILD | Gilead Sciences Inc | $133.21 | +1.80% | — | 165.85B |
| VRTX | Vertex Pharmaceuticals Inc | $496.07 | +2.49% | 28.3 | 124.51B |
| REGN | Regeneron Pharmaceuticals | $784.36 | +1.59% | 18.4 | 79.53B |
| ALNY | Alnylam Pharmaceuticals Inc | $219.20 | +1.43% | 35.2 | 28.41B |